Risk factors for acute myocardial infarction in patients with alcohol-related cirrhosis - a Danish nested

Emma Celia Herting1,2, Rasmine Birn-Rydder1,2, Konstantin Kazankov1,2

  • 1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Insights

Patients with alcohol-related cirrhosis (ALD cirrhosis) face increased risks for myocardial infarction (MI) due to factors like infection and heart failure. Anticoagulants may offer protection against MI in this population.

Area of Science:

  • Cardiology
  • Hepatology
  • Public Health

Background:

  • Alcohol-related cirrhosis (ALD cirrhosis) presents a complex relationship with arterial and venous thrombotic events.
  • The specific risk factors for acute myocardial infarction (MI) in patients with ALD cirrhosis remain incompletely understood.

Purpose of the Study:

  • To identify and analyze the key risk factors associated with acute myocardial infarction (MI) among patients diagnosed with alcohol-related cirrhosis (ALD cirrhosis).

Main Methods:

  • A nationwide, register-based, nested case-control study was conducted using Danish patient data from 2000-2019.
  • Cases were patients with a first-time MI post-ALD cirrhosis diagnosis; controls (10:1 ratio) were matched cohort members without MI history.
  • Conditional logistic regression analyzed associations between pre-selected risk factors and MI odds.

Main Results:

  • Key MI risk factors identified in ALD cirrhosis patients include hospitalization for infection, recent surgery, and pre-existing atherosclerosis.
  • Comorbidities such as cardiac ischemia, heart failure, and chronic obstructive pulmonary disease (COPD) significantly elevated MI risk.
  • Anticoagulant use demonstrated a protective effect against MI in this cohort.

Conclusions:

  • This study elucidates significant risk factors for MI in patients with ALD cirrhosis, including infections, surgery, and cardiovascular comorbidities.
  • Findings highlight the potential clinical utility of risk factor assessment and thromboprophylaxis in managing MI risk in ALD cirrhosis patients.
Abstract